COV (NYSE)

Price:$65.80
Change:0.26
Volume:2,978,444
As of May 21 2013 4:00PM
Minimum 20 minute delay

  • 5/21/2013 6:59:33 AM

    Covidien’s Technology Platform to Diagnose Early Lung Cancer Part of New Guidelines of American College of Chest Physicians

    Minimally invasive procedure aids early detection and diagnosis of lung cancer, potentially increasing long-term survival rates significantly MINNEAPOLIS--(BUSINESS WIRE)--May. 21, 2013-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that its …

  • 5/20/2013 8:00:00 AM

    Covidien Receives FDA 510(k) Clearance for Nellcor™ Pulse Oximetry Motion Claims

    Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo.--(BUSINESS WIRE)--May. 20, 2013-- Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that its Nellcor™ pulse oximetry portfolio, which is used to measure arter…

  • 5/13/2013 4:01:00 PM

    Covidien Announces Pricing of $750 Million Senior Notes Offering

    DUBLIN--(BUSINESS WIRE)--May. 13, 2013-- Covidien plc (NYSE: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), priced an underwritten offering of $750 million aggregate principal amount of 2.950% senior notes due 2023. The offering is expected to close on …

  • 5/13/2013 9:00:00 AM

    Covidien Announces Senior Notes Offering

    DUBLIN--(BUSINESS WIRE)--May. 13, 2013-- Covidien plc (NYSE: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), launched an underwritten offering of senior notes. These notes will be fully and unconditionally guaranteed on a senior unsecured basis by …

A Partner in Health

Collaborating with physicians and other healthcare professionals, focusing on research and development and maintaining clinical leadership add up to innovative medical solutions that make a difference.

Conscientious Collaboration

Ensuring ethical interactions with healthcare professionals is vital to the global healthcare environment. Covidien’s Conscientious Collaboration platform is our commitment to open communications about the need to ensure compliant interactions with our customers and partners.

One Covidien

One look. One Covidien. Experience the new unified look of Covidien. Easy-to-use labeling. New outside packaging with the same quality products inside. First-class service and support.

Visit Us